醫療護送服務市場按服務類型、患者類型、最終用途和地區分類

2025 年全球醫療陪同服務市場規模估計為 4,860 萬美元，預計到 2032 年將達到 8,120 萬美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.6%。

圖。

近年來，由於對優質醫療服務和對有長期醫療需求的患者支持的需求不斷增加，全球醫療護送服務市場取得了顯著成長。醫療陪同服務為患者提供導航、翻譯、運輸、護送和其他非臨床服務，以確保他們得到最佳護理。隨著與文明病和老齡化相關的疾病的增加，越來越多的患者選擇這些輔助服務以簡化後勤並確保治療和復原過程中的心理支持。

市場動態：

推動醫療陪伴服務市場成長的關鍵因素是老年人口的增加（老年人更容易患慢性病）、人們越來越關注整體健康而不僅僅是臨床治療，以及看護者的短缺。然而，資料隱私問題和法規合規問題帶來了挑戰。從積極的一面來看，醫療旅遊業的快速擴張和個人化醫療革命正在創造有利可圖的機會。此外，先進的數位解決方案的整合，用於服務協調和改善農村地區的接入，可能會在未來進一步加速市場擴張。

本研究的主要特點

本報告對全球醫療陪同服務市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了關於市場促進因素、限制因素、機會、新服務的推出和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。

全球醫療陪同服務市場的主要企業是根據公司亮點、服務組合、關鍵亮點、財務績效和策略等參數進行的分析。

研究中介紹的主要企業包括葛蘭素史克公司、Sanaria Inc.、Nobelpharma Co.、Sumaya Biotech、GenVec、默克公司、輝瑞公司、強生公司、Bharat Biotech、印度血清研究所、武田製藥工業、Vaxart, Inc. 和 BioNTech。

本報告的見解將幫助負責人和企業經營團隊就未來的發布、擴張、合作和行銷策略做出明智的決策。

全球醫療陪同服務市場報告針對該行業的各個相關人員，包括服務供應商、醫療機構、付款人、監管機構和新進入者。

透過本研究提供的各種市場資料分析，相關人員將更容易做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 主要進展
• 監管情景
• 產品發布/核准
• PEST分析
• PORTER 分析
• 併購情景
• 產業趨勢

4. 2020 年至 2032 年全球醫療陪護服務市場（按服務類型分類）（百萬美元）

• 醫療支援服務
• 運輸服務
• 情感支持服務
• 其他（個人護理服務）

5. 2020 年至 2032 年全球醫療陪護服務市場（依病患類型分類）（百萬美元）

• 年齡較大
• 慢性病
• 阻礙
• 精神疾病
• 術後
• 孩子們

6. 全球醫療護送服務市場，依最終用途，2020-2032 年（百萬美元）

• 醫院
• 診所
• 家庭保健提供者
• 安養院及輔助生活設施
• 復健中心

7. 2020 年至 2032 年全球醫療陪護服務市場按地區分類的價值（百萬美元）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• GlaxoSmithKline plc
• Sanaria Inc.
• Nobelpharma Co.
• Sumaya Biotech
• GenVec
• Merck & Co., Inc.
• Pfizer Inc.
• Johnson & Johnson
• Bharat Biotech
• Serum Institute of India
• Takeda Pharmaceutical Company
• Novavax, Inc.
• Inovio Pharmaceuticals
• Vaxart, Inc.
• BioNTech SE

第 9 章分析師建議

• 命運之輪
• 分析師觀點
• 一致的機會圖

第10章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Global Medical Accompaniment Service Market is estimated to be valued at US$ 48.6 Mn in 2025 and is expected to reach US$ 81.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.

Figure. Medical Accompaniment Service Market Share (%), By Region 2025

The global medical accompaniment service market has been witnessing significant growth in the recent past owing to the rising demand for quality healthcare services and support for patients requiring long-term medical care. Medical accompaniment services help patients in navigation, translation, transportation, companionship, and other non-clinical services allowing them to receive optimal care. As lifestyle diseases and age-related illnesses are on the rise, more patients are opting for these supplementary services to simplify logistics and ensure emotional support during their treatment or recovery process.

Market Dynamics:

The primary growth drivers for the medical accompaniment service market include growing geriatric population base susceptible to chronic diseases, increasing preference for holistic wellness over mere clinical treatment, and shortage of caretakers. However, data privacy concerns and legal compliance issues pose challenges. On the positive side, rapid medical tourism expansion and personalized healthcare revolution are opening lucrative opportunities. Moreover, integration of advanced digital solutions for service coordination and improved access in rural regions can further accelerate the market expansion going forward.

Key Features of the Study:

This report provides in-depth analysis of the global medical accompaniment service market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new service launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global medical accompaniment service market based on the following parameters - company highlights, service portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Sumaya Biotech, GenVec, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Bharat Biotech, Serum Institute of India, Takeda Pharmaceutical Company, Novavax, Inc., Inovio Pharmaceuticals, Vaxart, Inc., and BioNTech SE

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future service launches, expansions, collaborations and marketing tactics

The global medical accompaniment service market report caters to various stakeholders in this industry including service providers, healthcare organizations, payers, regulators and new entrants

Stakeholders would have ease in decision-making through various market data analyses provided in the study

Market Segmentation

• By Service Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Medical Assistance Services
  • Transportation Services
  • Emotional Support Services
  • Others (Personal Care Service)
• By Patient Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Elderly Patients
  • Patients with Chronic Illnesses
  • Disabled Patients
  • Mentally Ill Patients
  • Post-operative Patients
  • Pediatric Patients
• By End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals
  • Clinics
  • Home Healthcare Providers
  • Nursing Homes and Assisted Living Facilities
  • Rehabilitation Centers
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • GlaxoSmithKline plc
  • Sanaria Inc.
  • Nobelpharma Co.
  • Sumaya Biotech
  • GenVec
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Bharat Biotech
  • Serum Institute of India
  • Takeda Pharmaceutical Company
  • Novavax, Inc.
  • Inovio Pharmaceuticals
  • Vaxart, Inc.
  • BioNTech SE

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Medical Accompaniment Service Market, By Service Type
  • Global Medical Accompaniment Service Market, By Patient Type
  • Global Medical Accompaniment Service Market, By End User
  • Global Medical Accompaniment Service Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Medical Accompaniment Service Market, By Service Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Medical Assistance Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Transportation Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Emotional Support Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Personal Care Service)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Medical Accompaniment Service Market, By Patient Type, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Elderly Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Patients with Chronic Illnesses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Disabled Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Mentally Ill Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Post-operative Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Pediatric Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Medical Accompaniment Service Market, By End User, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Home Healthcare Providers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Nursing Homes and Assisted Living Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Rehabilitation Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Medical Accompaniment Service Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanaria Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nobelpharma Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sumaya Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GenVec
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bharat Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Serum Institute of India
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takeda Pharmaceutical Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novavax, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Inovio Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vaxart, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioNTech SE
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us